Effect of Metallic Nanoparticles on Nosocomial Bacteria
NCT04775238 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2021-03-03
Summary
This research aims to study the properties of metallic nanoparticles"MNPs" (silver nanoparticles "AgNps" and copper nanoparticles "CuNps") on the 2 most common nosocomial bacteria which are highly resistant to antibiotics including Staphylococcus aureus and Pseudomonas aeruginosa, to evaluate the growth inhibiting properties of MNPs on all bacterial isolates, to evaluate the biofilm inhibitory effect on biofilm forming bacterial isolates and the synergistic effect of these MNPs in combination with antibiotics on the antibiotic resistant isolates.
Conditions
- Nosocomial Infections
Interventions
- OTHER
-
Silver nanoparticles
AgNPs (19±5 nm)
- OTHER
-
Copper nanoparticles
CuNPs (150-350 nm)
Sponsors & Collaborators
-
Sohag University
lead OTHER
Principal Investigators
-
Nahed Fathallah, lecturer · Sohag University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-27
- Primary Completion
- 2021-06-20
- Completion
- 2021-07-01
Countries
- Egypt
Study Locations
More Related Trials
-
Phage Therapy for the Prevention and Treatment of Pressure Ulcers.
NCT04815798 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Microbial Infection and AMR in Hospitalized Patients With Covid 19
NCT04479982 ·Status: UNKNOWN
-
S. Aureus Screening and Decolonization
NCT02182115 ·Status: COMPLETED ·Phase: PHASE4
-
Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant
NCT00518076 ·Status: UNKNOWN
-
Development and Validation of (Bio)Sensors for the Identification of Pathogens
NCT06548841 ·Status: COMPLETED
-
Challenge of the Nasopharynx With Neisseria Lactamica Expressing the Meningococcal Protein Neisseria Adhesin A (NadA)
NCT03630250 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients
NCT01746654 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Efficacy and Safety of Nano-S1
NCT05822180 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections
NCT00463801 ·Status: TERMINATED ·Phase: PHASE4
-
Genetic Diversity of Toxoplasma Gondii in Cancer Patients
NCT04834076 ·Status: UNKNOWN
-
Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
NCT00548002 ·Status: COMPLETED
-
Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
NCT00773864 ·Status: UNKNOWN
-
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
NCT01234831 ·Status: COMPLETED ·Phase: NA
-
Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives
NCT01184339 ·Status: COMPLETED
-
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
NCT03162250 ·Status: COMPLETED ·Phase: PHASE1
-
Experimental Phage Therapy of Bacterial Infections
NCT00945087 ·Status: UNKNOWN ·Phase: NA
-
An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS
NCT00754273 ·Status: COMPLETED
-
Microbiological Study in Neck Space Infections: A Clinical and Microbiological Correlation
NCT07184515 ·Status: NOT_YET_RECRUITING
-
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
NCT00622882 ·Status: UNKNOWN ·Phase: NA
-
Antimicrobial Drug Use and Resistant Staphylococcus Aureus
NCT01075451 ·Status: COMPLETED
-
Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
NCT01105767 ·Status: COMPLETED ·Phase: NA
-
Staph Household Intervention for Eradication (SHINE)
NCT02572791 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Evaluation of the Residual Antimicrobial Activity
NCT04495920 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial
NCT02223520 ·Status: COMPLETED ·Phase: NA
-
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
NCT01671358 ·Status: COMPLETED